Learning Center
Post-Insertion Infection Prevention: Global Insights and Practical Frameworks for Vascular Access Teams [virtual]
Includes a Live Web Event on 04/12/2026 at 8:00 AM (EDT)
Intravascular catheters are among the most frequently used medical devices in healthcare. Their widespread use—across millions of insertions, access procedures, and maintenance events—significantly increases the risk of healthcare-associated infections.
The purpose of this presentation is to provide a framework that vascular access team (VAT) members can use to reduce the risk of post-insertion infections associated with vascular access devices (VADs). Recent U.S. and international infection prevention (IP) research highlights a growing number of emerging issues and recommended interventions relevant to vascular access teams (VATs). These include hand hygiene adherence, proper use of personal protective equipment, and environmental exposure risks such as contaminated sinks.
New federal legislation on hospital-onset bacteremia has expanded prevention efforts to all VADs, not just central lines. Additional focus areas include defining core components of infection risk mitigation, gaining leadership support, and optimizing catheter placement to reduce infection. Advances in antimicrobial dressings, blood culture contamination reduction, and updated IP strategies for peripheral IVs are also emphasized.
Finally, monitoring post-insertion care with attention to bundle compliance remains a key priority. A review of emerging IP issues will inform necessary updates to VAD clinical practice protocols. These revisions aim to enhance patient safety by strengthening infection prevention across assessment, insertion, and maintenance practices.
Learning Objectives: By the end of this session, participants will be able to:
- Summarize the emerging IP issues that will influence VAD practice.
- Summarize new peer-reviewed studies and expert guideline recommendations that impact VAD practice.
- Reproduce a listing of emerging IP intervention considerations that reflect recent research findings.
Contact Hours: 1
CRNI® RUs: 2
Robert Garcia, MT(ASCP), CIC, FAPIC
Robert Garcia is an infection preventionist/consultant and has been a member of the Association for Professionals in Infection Control and Epidemiology (APIC) since 1980. In 2016, he was selected as a fellow at the Association for Professionals in Infection Control and Epidemiology (APIC), a designation for experienced IPs who have had significant contributions to the field of infection prevention. He is the certification infection preventionist/director at nine hospitals in New York City and the principal researcher on the effectiveness of silver-hydrogel urinary catheters, chlorhexidine skin antisepsis, and comprehensive oral care. Robert is a current or former member of APIC’s National Strategic Planning Board, Education Committee, and/or CBIC, as well as a trainer for APIC’s EPI Clinical Course. He is a contributor to APIC’s Text of Infection Control and Epidemiology; was a reviewer for the 2005 HICPAC Guidelines on Isolation; and since 2001 has been an editorial board member and/or reviewer for the American Journal of Infection Control, where in 2016 he was ranked among the top 25th percentile of reviewers. He has more than 100 publications and media interviews ranging from institutional costs of infection to prevention of HAIs to environmental contamination to microbiology to reducing occupational exposures.
